Emergent BioSolutions
EBS
#8180
Rank
โ‚น33.15 B
Marketcap
โ‚น646.54
Share price
-5.68%
Change (1 day)
-41.61%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2026 (TTM): -โ‚น327.18

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is -โ‚น326.59. In 2025 the company made an earnings per share (EPS) of โ‚น90.19 an increase over its 2024 EPS that were of -โ‚น344.63.

EPS history for Emergent BioSolutions from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น327.18-462.76%
2025โ‚น90.19-126.17%
2024-โ‚น344.63-75.61%
2023-โ‚น1,413232.21%
2022-โ‚น425.33-203.46%
2021โ‚น411.09-25.09%
2020โ‚น548.75445.28%
2019โ‚น100.64-15.2%
2018โ‚น118.68-35.9%
2017โ‚น185.1369.57%
2016โ‚น109.18-27.67%
2015โ‚น150.9565.63%
2014โ‚น91.1411.63%
2013โ‚น81.6532.31%
2012โ‚น61.71

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น72.15-122.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น120.15-136.79%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น303.58-192.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-โ‚น170.89-47.67%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚น50.32-115.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น412.99 26.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น59.81-118.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel